Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-24-006170

EVP R&D, Chief Medical Officer gave up 8,523 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 19,194 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2024-02-18 Option exercise +8,897 96,834 D
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2024-02-18 Shares withheld for taxes −3,951 $32.18 $127,143 92,883 D
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2024-02-20 Option exercise +10,297 103,180 D
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2024-02-20 Shares withheld for taxes −4,572 $30.39 $138,943 98,608 D
Derivatives
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2024-02-18 Option exercise · Restricted Stock Unit Award −8,897 17,793 D
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2024-02-20 Option exercise · Restricted Stock Unit Award −10,297 0 D
Loading xslF345X05/form4.xml…